Company Overview
| Stock Name | Uni Medical |
|---|---|
| Stock Code | 02666 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 向醫院客戶提供一系列綜合醫療服務,包括設備融資(以融資租賃服務方式提供)、醫療行業、設備及融資諮詢服務及科室升級服務 |
| Listing Date | 2015-07-08 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市西城區西直門外大街6號中儀大廈9樓 |
| Business Address (Hong Kong) | 香港灣仔港灣道1號會展廣場辦公大樓3302-3303室 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | universalmsm.com |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 8.18 / shares |
| Offer Price Range | To be extracted |
| Lot Size | 500 shares |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2015-06-24 to 2015-06-29 |
| Global Offering Shares | 423,189,500 shares |
| HK Public Offer Shares (Initial) | 42,319,000 shares (10.0%) |
| Public Offer Lots (Initial) | 84,638lots (Pool A42,319lots,Pool B42,319lots) |
| International Placing Shares (Initial) | 380,870,500 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 1,692,755,580 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 11.4% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 3,461,690,110 |
Stock Connect Inclusion Analysis
| Avg Daily HK Mkt Cap | HK$ 10.4B |
|---|---|
| Analysis Result | Already included in Stock Connect (both) |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣456.6百萬元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2012 | 2013 | 2014 |
|---|---|---|---|
| Revenue | 593,326 | 981,458 | 1,552,682 |
| Cost of sales | -204,781 | -348,619 | -619,594 |
| Gross profit | 388,545 | 632,839 | 933,088 |
| Other income and gains, net | 6,393 | 54,887 | 15,419 |
| Selling and distribution expenses | -70,296 | -106,874 | -126,295 |
| Administrative expenses | -77,037 | -154,395 | -190,614 |
| Profit before tax | 239,148 | 418,344 | 611,082 |
| Income tax expense | -61,496 | -105,606 | -154,444 |
| Profit for the year | 177,652 | 312,738 | 456,638 |
| Profit attributable to owners | 177,652 | 312,738 | 456,638 |
Balance Sheet
| Item | 2012 | 2013 | 2014 |
|---|---|---|---|
| Cash and cash equivalents | 307,980 | 318,998 | 453,569 |
| Inventories | 3,775 | 3,321 | 3,119 |
| Total current assets | 1,967,417 | 3,170,210 | 4,759,911 |
| Total assets | 5,883,444 | 10,452,434 | 16,385,316 |
| Total current liabilities | 2,886,562 | 3,992,250 | 5,412,449 |
| Total liabilities | 5,027,441 | 9,283,691 | 13,957,817 |
| Total equity | 856,003 | 1,168,743 | 2,427,499 |
| Equity attributable to owners | 856,003 | 1,168,743 | 2,427,499 |
| Interest-bearing borrowings | 3,788,699 | 7,905,816 | 11,408,252 |
Cash Flow Statement
| Item | 2012 | 2013 | 2014 |
|---|---|---|---|
| Net cash from operating activities | -1,592,904 | -4,119,417 | -4,110,715 |
| Net cash from investing activities | -60,492 | -582 | -741 |
| Net cash from financing activities | 1,679,992 | 4,140,880 | 4,247,903 |
| Net increase in cash | 26,596 | 20,881 | 136,447 |
| Depreciation of PP&E | 8,560 | 16,339 | 15,150 |
| Purchase of PP&E | -60,492 | -582 | -741 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 5.0 |
|---|---|
| First Day Open | HK$ 6.11 |
| First Day Change | -38.88% |
| First Day Volume | 74161000.0 |
| First Day Turnover | 414503000.0 |
| Use of Proceeds | 1、約45.0%將用作加強我們的資本資源,以支持我們融資租賃業務的持續發展,主要用于醫療行業;
2、約20.0%將用作開發醫院信息化服務,以配合我們現有的綜合解決方案;我們擬為技術解決方案團隊增聘人手以擴充其陣容,以及開發一套自有的醫院信息管理系統;我們亦計劃獲得有關醫院信息化服務的服務,并于實施醫院信息化服務時將部分所得款項為醫院客戶提供資金;
3、約15.0%將用作發展我們的醫院托管業務;
4、約10.0%將用作進一步發展腦卒中項目解決方案及其他高需求領域用的其他新科室升級服務;
5、約10.0%將作為一般企業用途所需資金。 |
Underwriting Syndicate
Joint Sponsors (2)
Overall Coordinators (2)
Joint Bookrunners (7)
Joint Lead Managers (7)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Estate Summer Limited | 77,513,680 HKD | — | 0.60% | — | 6 months | 2016-01-08 |
| 2 | Heywin Investments Limited | 77,513,680 HKD | — | 0.60% | — | 6 months | 2016-01-08 |
| 3 | Nikko Asset Management Asia Limited | 155,035,540 HKD | — | 1.10% | — | 6 months | 2016-01-08 |
| 4 | Yi Fang Da Elite Inv. Limited | 232,557,400 HKD | — | 1.70% | — | 6 months | 2016-01-08 |
| 5 | 北京慈航投资基金管理有限公司 | 232,557,400 HKD | — | 1.70% | — | 6 months | 2016-01-08 |
| 6 | 广发基金管理有限公司 | 232,557,400 HKD | — | 1.70% | — | 6 months | 2016-01-08 |
| 7 | 恒健国际投资控股(香港)有限公司 | 77,513,680 HKD | — | 0.60% | — | 6 months | 2016-01-08 |
| 8 | 京投(香港)有限公司 | 155,035,540 HKD | — | 1.10% | — | 6 months | 2016-01-08 |
| 9 | 中国南车(香港)有限公司 | 232,557,400 HKD | — | 1.70% | — | 6 months | 2016-01-08 |
| 10 | 中新融创资本管理有限公司 | 77,513,680 HKD | — | 0.60% | — | 6 months | 2016-01-08 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 陳仕俗 | — |
| Company Secretary | 鄭碧玉 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 通用技術集團(透過香港資本及通用諮詢香港)合共持股38.25%;中信資本持股14.43%;工銀國際持股7.16%;捷道有限公司持股5.70%(由周大福企業有限公司最終擁有) |
|---|




